Loading the SOTA2 catalog…
Rho
AI-driven opportunistic screening system for low bone mineral density using routinely captured x-rays.
What is Rho?
AI-driven opportunistic screening system for low bone mineral density using routinely captured x-rays. Licensed by Health Canada; FDA De Novo Marketing Authorization.
Product typeDiagnostics & Imaging
Pricing ·
Deployment
APINot available
What teams use Rho for
AI-assisted bone age assessment
opportunistic screening for osteoporosis risk
improving population bone health
reducing inter-rater variability in imaging assessments
Integrations and access
Platforms, integrations, and language support vary by plan and region. Confirm final requirements with the vendor.
Platforms
IntegrationsAPI and webhooks
Languages
Support
What reviewers say
Community reviewsReviews are owned and editable by their authors.
Sign in to reviewLoading community reviews…
Enterprise readiness
Compliance claims are normalized from current vendor documentation and independently reviewed by SOTA2.
commercially acceptable means to protect personal data
Data retention:
Benchmarks and comparisons
Independent benchmarksStructured task results are being verified.
Side-by-side comparisonsComparison workspaces will be available in a later release.
